49 related articles for article (PubMed ID: 21816220)
1. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.
Pettazzoni P; Ciamporcero E; Medana C; Pizzimenti S; Dal Bello F; Minero VG; Toaldo C; Minelli R; Uchida K; Dianzani MU; Pili R; Barrera G
Free Radic Biol Med; 2011 Oct; 51(8):1610-8. PubMed ID: 21816220
[TBL] [Abstract][Full Text] [Related]
2. Torachrysone-8-O-β-d-glucoside mediates anti-inflammatory effects by blocking aldose reductase-catalyzed metabolism of lipid peroxidation products.
Zhao WL; Xu D; Wang JS
Biochem Pharmacol; 2023 Dec; 218():115931. PubMed ID: 37981172
[TBL] [Abstract][Full Text] [Related]
3. Preferential recognition of auto-antibodies against 4-hydroxynonenal modified DNA in the cancer patients.
Faisal M; Shahab U; Alatar AA; Ahmad S
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28105689
[TBL] [Abstract][Full Text] [Related]
4. Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.
Čipak Gašparović A; Milković L; Dandachi N; Stanzer S; Pezdirc I; Vrančić J; Šitić S; Suppan C; Balic M
Antioxidants (Basel); 2019 Dec; 8(12):. PubMed ID: 31835715
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 promotes metastasis and relapse in HER2-positive breast cancer.
Andreani C; Bartolacci C; Persico G; Casciaro F; Amatori S; Fanelli M; Giorgio M; Galié M; Tomassoni D; Wang J; Zhang X; Bick G; Coppari R; Marchini C; Amici A
Sci Rep; 2023 Dec; 13(1):22000. PubMed ID: 38081972
[TBL] [Abstract][Full Text] [Related]
6. Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer.
Tossetta G; Fantone S; Marzioni D; Mazzucchelli R
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296999
[TBL] [Abstract][Full Text] [Related]
7. Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer.
Perkovic MN; Jaganjac M; Milkovic L; Horvat T; Rojo D; Zarkovic K; Ćorić M; Hudolin T; Waeg G; Orehovec B; Zarkovic N
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671530
[TBL] [Abstract][Full Text] [Related]
8. NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression.
Buttari B; Arese M; Oberley-Deegan RE; Saso L; Chatterjee A
Front Physiol; 2022; 13():989793. PubMed ID: 36213236
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation.
Mao LJ; Kan Y; Li BH; Ma S; Liu Y; Yang DL; Yang C
Front Oncol; 2020; 10():421. PubMed ID: 32318337
[TBL] [Abstract][Full Text] [Related]
10. Lipoxidation and cancer immunity.
Martín-Sierra C; Laranjeira P; Domingues MR; Paiva A
Redox Biol; 2019 May; 23():101103. PubMed ID: 30658904
[TBL] [Abstract][Full Text] [Related]
11. Controversy about pharmacological modulation of Nrf2 for cancer therapy.
Milkovic L; Zarkovic N; Saso L
Redox Biol; 2017 Aug; 12():727-732. PubMed ID: 28411557
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 4-hydroxynonenal-induced p53-mediated apoptosis in prostate cancer cells LNCaP and DU145.
Cao ZG; Xu X; Xue YM; Zhao SL
Contemp Oncol (Pozn); 2014; 18(1):22-8. PubMed ID: 24876817
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of the Nfe2-related factor (Nrf) transcription factor family in the zebrafish, Danio rerio.
Williams LM; Timme-Laragy AR; Goldstone JV; McArthur AG; Stegeman JJ; Smolowitz RM; Hahn ME
PLoS One; 2013; 8(10):e79574. PubMed ID: 24298298
[TBL] [Abstract][Full Text] [Related]
14. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.
Dalleau S; Baradat M; Guéraud F; Huc L
Cell Death Differ; 2013 Dec; 20(12):1615-30. PubMed ID: 24096871
[TBL] [Abstract][Full Text] [Related]
15. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.
Jung KA; Kwak MK
Oxid Med Cell Longev; 2013; 2013():423965. PubMed ID: 23766854
[TBL] [Abstract][Full Text] [Related]
16. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo.
Miller DM; Singh IN; Wang JA; Hall ED
Free Radic Biol Med; 2013 Apr; 57():1-9. PubMed ID: 23275005
[TBL] [Abstract][Full Text] [Related]
17. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal.
Huang Y; Li W; Kong AN
Cell Biosci; 2012 Nov; 2(1):40. PubMed ID: 23190551
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and lipid peroxidation products in cancer progression and therapy.
Barrera G
ISRN Oncol; 2012; 2012():137289. PubMed ID: 23119185
[TBL] [Abstract][Full Text] [Related]
19. Protein modification by oxidized phospholipids and hydrolytically released lipid electrophiles: Investigating cellular responses.
Ullery JC; Marnett LJ
Biochim Biophys Acta; 2012 Oct; 1818(10):2424-35. PubMed ID: 22562025
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
